Gene Silencing/Gene Editing
News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests
Sherlock Biosciences said that under the agreement, Rokline Health will develop and manufacture high-throughput CRISPR kits in the US.
Sherlock Bio Foundation Licenses CRISPR Tech to LogicInk
LogicInk said it will use the CRISPR technology to develop an instrument-free diagnostic biosensor for the detection of SARS-CoV-2.
As diagnostics firms develop a new wave of COVID-19 tests using next-gen sequencing, TGen researchers are also adding CRISPR-based sample prep to their kit.
Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test
The diagnostic is composed of Agilent's Bravo automation workstation and Mammoth's DETECTR BOOST SARS-CoV-2 assay.
DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech
The contract was awarded under DARPA's Detect It with Gene Editing Technologies program, which aims to create a device to detect at least 10 pathogens.